HK29496A - Gamma interferon formulation - Google Patents
Gamma interferon formulationInfo
- Publication number
- HK29496A HK29496A HK29496A HK29496A HK29496A HK 29496 A HK29496 A HK 29496A HK 29496 A HK29496 A HK 29496A HK 29496 A HK29496 A HK 29496A HK 29496 A HK29496 A HK 29496A
- Authority
- HK
- Hong Kong
- Prior art keywords
- gamma interferon
- interferon formulation
- formulation
- gamma
- interferon
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/21—Interferons [IFN]
- A61K38/217—IFN-gamma
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US11643487A | 1987-11-03 | 1987-11-03 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HK29496A true HK29496A (en) | 1996-02-23 |
Family
ID=22367187
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HK29496A HK29496A (en) | 1987-11-03 | 1996-02-15 | Gamma interferon formulation |
Country Status (15)
| Country | Link |
|---|---|
| EP (1) | EP0386106B1 (xx) |
| JP (1) | JP2732877B2 (xx) |
| KR (1) | KR890701135A (xx) |
| AU (1) | AU621327B2 (xx) |
| CA (1) | CA1335176C (xx) |
| DD (1) | DD289470A5 (xx) |
| DE (1) | DE3888197T2 (xx) |
| HK (1) | HK29496A (xx) |
| HU (1) | HU210530A9 (xx) |
| IE (1) | IE60875B1 (xx) |
| IL (1) | IL88233A (xx) |
| NZ (1) | NZ226791A (xx) |
| PT (1) | PT88918B (xx) |
| WO (1) | WO1989004177A1 (xx) |
| ZA (1) | ZA888249B (xx) |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5981485A (en) | 1997-07-14 | 1999-11-09 | Genentech, Inc. | Human growth hormone aqueous formulation |
| IT1246296B (it) * | 1990-07-25 | 1994-11-17 | Sclavo Spa | Procedimento di estrzione e purificazione del gamma interferone umano ricombinante |
| IL109350A (en) * | 1993-05-12 | 2001-01-28 | Genentech Inc | Stable liquid preparations of gamma interferon |
| TW249202B (xx) * | 1993-08-13 | 1995-06-11 | Ciba Gerigy Corp | |
| IT1272252B (it) | 1994-05-16 | 1997-06-16 | Applied Research Systems | Formulazioni liquide di interferone beta |
| US5453425A (en) * | 1994-07-11 | 1995-09-26 | Janssen Pharmaceutica N.V. | Risperidone oral formulation |
| US5766582A (en) * | 1994-10-11 | 1998-06-16 | Schering Corporation | Stable, aqueous alfa interferon solution formulations |
| ATE209930T1 (de) | 1995-03-21 | 2001-12-15 | Applied Research Systems | Flüssige hcg-formulierungen |
| TW426523B (en) * | 1995-04-06 | 2001-03-21 | Hoffmann La Roche | Interferon solution |
| US20030190307A1 (en) | 1996-12-24 | 2003-10-09 | Biogen, Inc. | Stable liquid interferon formulations |
| JPH1149698A (ja) * | 1997-07-31 | 1999-02-23 | Santen Pharmaceut Co Ltd | 安定性を向上させたラクトフェリンの水性製剤 |
| CA2325442C (en) * | 1998-04-02 | 2011-10-11 | Genentech, Inc. | Treatment of cardiac hypertrophy using interferon-gamma |
| LT4947B (lt) | 2001-09-26 | 2002-08-26 | Biotechnologijos Institutas | Interferono alfa farmacinė kompozicija |
| WO2003026686A1 (en) * | 2001-09-27 | 2003-04-03 | Pomytkin Igor A | Potentiating the therapeutic effects of interferons |
| CU23432B6 (es) | 2005-11-02 | 2009-10-16 | Ct Ingenieria Genetica Biotech | Formulaciones estabilizadas que contienen a los interferones gamma y alfa en proporciones potenciadoras |
| JP5137055B2 (ja) * | 2006-03-10 | 2013-02-06 | 塩野義製薬株式会社 | 安定化されたインターフェロン−γ組成物 |
| DE102007050165B4 (de) * | 2007-10-19 | 2010-06-17 | Stiftung Tierärztliche Hochschule Hannover | Stabilisierte Lösung, Verfahren zu deren Herstellung sowie deren Verwendung und Arzneimittel in Form einer stabilisierten Lösung |
| JP2009091363A (ja) * | 2008-11-21 | 2009-04-30 | Asahi Kasei Pharma Kk | Ｐｔｈの安定化水溶液注射剤 |
| RU2564951C1 (ru) * | 2014-08-28 | 2015-10-10 | Закрытое акционерное общество "Вектор-Медика" (ЗАО "Вектор-Медика") | Композиция водного раствора рекомбинантного интерферона альфа-2 человека для ректального применения |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2834605A1 (de) * | 1978-08-07 | 1980-02-28 | Henkel Kgaa | Neue bis-aminopyridine, deren herstellung und verwendung als komponenten in oxidationshaarfarben sowie diese enthaltende haarfaerbemittel |
| EP0080879B1 (en) * | 1981-11-28 | 1986-10-01 | Sunstar Kabushiki Kaisha | Pharmaceutical composition containing interferon in stable state |
| JPS59175416A (ja) * | 1983-03-25 | 1984-10-04 | Sunstar Inc | 皮膚および粘膜の角化異常治療用外用剤 |
| JPS61277633A (ja) * | 1985-05-31 | 1986-12-08 | Toray Ind Inc | インタ−フエロン組成物 |
| DE3628468A1 (de) * | 1986-08-21 | 1988-03-03 | Thomae Gmbh Dr K | Neue applikationsformen fuer (alpha)-interferone |
-
1988
- 1988-10-30 IL IL88233A patent/IL88233A/xx not_active IP Right Cessation
- 1988-10-31 NZ NZ226791A patent/NZ226791A/en unknown
- 1988-11-01 AU AU27245/88A patent/AU621327B2/en not_active Expired
- 1988-11-01 IE IE329588A patent/IE60875B1/en not_active IP Right Cessation
- 1988-11-01 DE DE3888197T patent/DE3888197T2/de not_active Expired - Lifetime
- 1988-11-01 EP EP88910211A patent/EP0386106B1/en not_active Expired - Lifetime
- 1988-11-01 JP JP63509401A patent/JP2732877B2/ja not_active Expired - Lifetime
- 1988-11-01 WO PCT/US1988/003883 patent/WO1989004177A1/en active IP Right Grant
- 1988-11-02 PT PT88918A patent/PT88918B/pt not_active IP Right Cessation
- 1988-11-03 DD DD88321429A patent/DD289470A5/de unknown
- 1988-11-03 CA CA000582102A patent/CA1335176C/en not_active Expired - Lifetime
- 1988-11-03 ZA ZA888249A patent/ZA888249B/xx unknown
-
1989
- 1989-07-01 KR KR1019890701229A patent/KR890701135A/ko not_active Application Discontinuation
-
1994
- 1994-09-01 HU HU94P/P00023P patent/HU210530A9/hu unknown
-
1996
- 1996-02-15 HK HK29496A patent/HK29496A/xx not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| NZ226791A (en) | 1990-04-26 |
| DE3888197T2 (de) | 1994-08-18 |
| IL88233A0 (en) | 1989-06-30 |
| WO1989004177A1 (en) | 1989-05-18 |
| DE3888197D1 (de) | 1994-04-07 |
| EP0386106A1 (en) | 1990-09-12 |
| DD289470A5 (de) | 1991-05-02 |
| PT88918A (pt) | 1988-12-01 |
| HU210530A9 (en) | 1995-04-28 |
| AU2724588A (en) | 1989-06-01 |
| KR890701135A (ko) | 1989-12-19 |
| IE883295L (en) | 1989-05-03 |
| CA1335176C (en) | 1995-04-11 |
| JP2732877B2 (ja) | 1998-03-30 |
| EP0386106B1 (en) | 1994-03-02 |
| IE60875B1 (en) | 1994-08-24 |
| PT88918B (pt) | 1993-01-29 |
| IL88233A (en) | 1993-08-18 |
| AU621327B2 (en) | 1992-03-12 |
| JPH03500882A (ja) | 1991-02-28 |
| ZA888249B (en) | 1990-07-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL88233A (en) | Gamma interferon formulation | |
| AU5502886A (en) | Stable gamma interferon formulation | |
| GB8727590D0 (en) | Formulation | |
| PH25793A (en) | Somatotropin formulation | |
| GB8712251D0 (en) | Formulation | |
| GB2207864B (en) | Antiviral composition comprising isopropyldeoxyuridine | |
| ZA862140B (en) | Stable gamma interferon formulation | |
| IE860756L (en) | Stable gamma interferon formulation | |
| GB8825541D0 (en) | Formulation | |
| GB8406910D0 (en) | Gamma interferon | |
| GB8714838D0 (en) | Formulation | |
| GB8730115D0 (en) | Formulation | |
| GB8713878D0 (en) | Formulation | |
| GB8706242D0 (en) | Formulation | |
| GB8729672D0 (en) | Formulation | |
| GB8713818D0 (en) | Formulation | |
| GB8720608D0 (en) | Formulation | |
| GB8720784D0 (en) | Formulation | |
| IE850680L (en) | Gamma interferon | |
| IE850068L (en) | Gamma interferon | |
| IE850134L (en) | Gamma interferon | |
| IE850135L (en) | Gamma interferon composition | |
| GB8728599D0 (en) | Novel formulation | |
| GB8728533D0 (en) | Novel formulation | |
| GB8727472D0 (en) | Powder formulation |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PF | Patent in force | ||
| PE | Patent expired |
Effective date: 20081031 |